Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-22-028008
Filing Date
2022-05-18
Accepted
2022-05-18 17:59:51
Documents
1
Period of Report
2022-05-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 4781
  Complete submission text file 0001213900-22-028008.txt   6065
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address
Tomsche David Scott (Reporting) CIK: 0001384044 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-12934 | Film No.: 22940576